Author

Jasmin A. Kruell

Koch Institute for Integrative Cancer Research At MIT

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Angela N. KoehleriD· 1 shared Becky S. LeiferiD· 1 shared Behnam NabetiD· 1 shared Flora Dievenich Braes· 1 shared Jérémie KalfoniD· 1 shared Kenneth EagleiD· 1 shared Kimberly StegmaieriD· 1 shared Maxim PimkiniD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Angela N. KoehlerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Rapid-kinetics degron benchmarking reveals off-target activities and mixed agonism-antagonism of MYB inhibitors

Taku Harada, Monika W. Perez, Jérémie Kalfon, Flora Dievenich Braes, Rashad Batley, Kenneth Eagle, Behnam Nabet, Becky S. Leifer, Jasmin A. Kruell, Vikram R. Paralkar, Kimberly Stegmaier, Angela N. Koehler, Stuart H. Orkin, Maxim Pimkin

The paper benchmarks six MYB inhibitors using a nascent transcriptomics assay, revealing partial specificity, off-target activity, and mixed agonism-antagonism effects.

bioRxiv · Apr 7, 2023 · PreprintMolecular Biology